Guided Therapeutics (GTHP) Revenue (2010 - 2025)
Guided Therapeutics (GTHP) reported Revenue of $590000.0 for Q4 2025, up 58900.0% on a YoY basis from N/an in Q4 2024, and up 883.33% sequentially from $60000.0 in Q3 2025.
Guided Therapeutics (GTHP) Revenue (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of Revenue data on file, last reported at $590000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 58900.0% year-over-year to $590000.0; the trailing twelve-month figure through Dec 2025 stood at $767000.0 (up 10857.14% YoY), and the FY2025 full-year result was $767000.0, up 10857.14% from the prior year.
- Revenue climbed to $590000.0 in Q4 2025, from $60000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $590000.0 in Q4 2025 to a low of $1000.0 in Q4 2024.
- A 5-year average of $69000.0 and a median of $20500.0 in 2021 frame the typical range for Revenue.
- Across the five-year window, Revenue slumped 96.88% in 2024 and soared 58900.0% in 2025, its largest moves.
- Tracing GTHP's Revenue over 5 years: stood at $60000.0 in 2021, then plunged by 95.0% to $3000.0 in 2022, then soared by 966.67% to $32000.0 in 2023, then tumbled by 96.88% to $1000.0 in 2024, then soared by 58900.0% to $590000.0 in 2025.
- Business Quant data shows GTHP's Revenue at $590000.0 in Q4 2025, $60000.0 in Q3 2025, and $117000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 590,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Jun 30, 2023 | 44,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 60,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Sep 30, 2020 | 77,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | 1,000.00 |
| Mar 31, 2019 | 18,000.00 |